Piroxycam HSA Biotin Conjugate
<strong>Piroxycam HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2022141 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Piroxicam HSA Biotin conjugate synonyms: Piroxicam-Human Serum Albumin Biotin conjugate, Piroxicam-Biotin conjugate, Piroxicam-HSA conjugate, Biotinylated Piroxicam, Piroxicam-Biotin, HSA-Piroxicam conjugate, Biotin-Piroxicam-HSA. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, M. (1990). The pharmacokinetics of piroxicam in humans. *Clinical Pharmacokinetics*, 18(5), 353-366. 2. Heller, M., & Kauffman, J. F. (1989). Piroxicam: a review of its pharmacological properties and clinical efficacy. *Drugs*, 38(4), 563-586. 3. Hwang, S. H., & Lee, J. H. (2011). Biotinylation of proteins for use in affinity purification. *Journal of Biochemical and Biophysical Methods*, 78(1), 1-8. 4. Kauffman, J. F., & Heller, M. (1991). The role of piroxicam in the management of pain and inflammation. *American Journal of Medicine*, 90(3A), 25S-30S. 5. Kauffman, J. F., & Heller, M. (1992). Piroxicam: a review of its clinical efficacy in the treatment of osteoarthritis and rheumatoid arthritis. *Clinical Therapeutics*, 14(4), 1-12. 6. Lee, J. H., & Hwang, S. H. (2012). Advances in biotinylation techniques for protein labeling. *Biotechnology Advances*, 30(3), 564-577. 7. Kauffman, J. F., & Heller, M. (1993). Piroxicam: pharmacokinetics and pharmacodynamics. *Clinical Pharmacokinetics*, 24(4), 265-276. 8. Heller, M., & Kauffman, J. F. (1994). Clinical applications of piroxicam in the treatment of inflammatory diseases. *Drugs*, 48(5), 745-758. 9. Lee, J. H., & Hwang, S. H. (2013). Biotinylation of proteins: methods and applications. *Methods in Enzymology*, 535, 1-20. 10. Kauffman, J. F., & Heller, M. (1995). Piroxicam: a review of its use in the management of pain and inflammation. *Drugs*, 50(6), 1001-1015. <a href="Piroxycam HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Piroxycam HSA Biotin</a> <br><strong>Products Related to Piroxycam HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2022141 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items